Filing Details

Accession Number:
0001209191-21-050626
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-10 16:53:10
Reporting Period:
2021-08-06
Accepted Time:
2021-08-10 16:53:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819790 Tarsus Pharmaceuticals Inc. TARS Biological Products, (No Disgnostic Substances) (2836) 814717861
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1827672 R. Bobak Azamian C/O Tarsus Pharmaceuticals, Inc.
15440 Laguna Canyon Road, Suite 160
Irvine CA 92618
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-06 1,616 $25.00 1,230,285 No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
Common Stock Disposition 2021-08-09 727 $25.00 1,229,558 No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
Common Stock Disposition 2021-08-09 100 $25.13 1,229,458 No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
No 4 S Indirect By the Bobak Azamian Living Trust established April 16, 2018
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,750 Direct
Footnotes
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021.
  2. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.